检索历史 清除

目的 观察沙利度胺(THD)体外抑制人胰腺癌细胞株SW1990增殖及诱导其凋亡的作用.方法 应用不同浓度的THD(3.125、6.25、12.5、25、50、100、200、400μg/ml)处理胰腺癌SW1990细胞24、48、72 h,用MTT法测定细胞的生长抑制率,流式细胞仪分析细胞周期,Annexin V/PI检测细胞凋亡率,蛋白质印迹法检测细胞Bcl-2、Bax蛋白的表达.结果 THD呈浓度和时间依赖性抑制胰腺癌细胞SW1990的生长.200μg/ml的THD干预使SW1990细胞G0/G1期比例从(41.15±2.23)％上升到(58.83 ±2.33)％；细胞凋亡率从2.6％增加到28.0％；细胞Bax蛋白表达量从0.17±0.03上调到0.33±0.04,Bcl-2蛋白表达量从0.35±0.02下调到0.17±0.01,Bcl-2/Bax比值从2.17±0.44下降到0.52±0.07.结论 THD可以抑制SW1990细胞增殖,其机制可能与上调Bax蛋白表达、下调Bcl-2蛋白表达,促进细胞凋亡,将细胞周期阻滞于G0/G1期有关.

Objective To investigate the effect of thalidomide on the proliferation and apoptosis in human pancreatic cancer cell SW1990 in vitro.Methods SW1990 cell line was treated with thalidomide at different concentrations (3.125,6.25,12.5,25,50,100,200 and 400 μg/ml) for 24,48,72 h,and then cell proliferation were evaluated by MTT.Cell cycle was determined by flow cytometry,apoptosis was determined by annexin V/PI fluos staining,Bcl-2,Bax protein expression and Bcl-2/Bax ratios were measured by Western Blot in vitro.Results Thalidomide inhibited the proliferation of SW1990 cells in a time and dosedependant manner.The proportion of G0/G1 phase of SW1990 cells with 200 μg/ml thalidomide treatment increased from (41.15 ± 2.23 ) ％ to (58.83 ± 2.33 ) ％,apoptosis rate increased from 2.6％ to 28.0％,the expression of Bax protein up-regulated from 0.17 ± 0.03 to 0.33 ± 0.04,the expression of Bcl-2 protein downregulated from 0.35 ± 0.02 to 0.17± 0.01,the ration of Bcl-2/Bax decreased from 2.17 ± 0.44 to 0.52 ±0.07.Conclusions Thalidomide can inhibit the proliferation of pancreatic cancer SW1990 cells by upregulating Bax,down-regulating Bcl-2,inducing cell apoptosis and cell Go/G1 phase arrest.